GormleyEA, LightnerDJ, BurgioKL, et al.: AUA/SUFU guideline: Diagnosis and treatment of overactive bladder (Non-neurogenic) in adults. J Urol, 2014; 188:2455–2463.
2.
GriffithsD: Neural control of micturition in humans: A working model. Nat Rev Urol, 2015; 12:695–705.
3.
VerhammeKMC, SturkenboomCJM, StrickerBH, BoschR: Drug-induced urinary retention–incidence, management and prevention. Drug Saf, 2008:31; 373–388.
4.
GupteKP, WenchenWu: Inpact of anticholinergic load of medications on the length of stay of cancer patients in hospice care. Int J Pharm Pract, 2015; 23:192–198.
5.
AsimakopoulosAD, De NunzioC, KocjancicE, et al.: Measurement of post-void residual urine. Neurourol Urodyn, 2016; 35:55–57.
6.
BarrettDM, WeinAJ: Voiding dysfunction. Diagnosis, classification, and management. In: GillenwaterJY, et al., (eds): Adult and Pediatric Urology, 2nd ed. St. Louis, Mo: Mosby Year Book, 1991, pp. 1001–1099.
7.
EllershawJ, WardC: Care of the dying patient: The last hours or days of life. BMJ, 2003; 326:30–34.
8.
NewmanDK: The indwelling urinary catheter: principles for best practice. J Wound Ostomy Continence Nurs, 2007; 34:655–661.
9.
ThompsonIM, LauvetzR: Oxybutynin in bladder spasm, neurogenic bladder, and enuresis. Urology, 1976; 8:452–454.
10.
Abrams P KelleherC, StaskinD, et al.: Combination treatment with mirabegron and solifenacin in patients with overactive bladder: Efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony). World J Urol, 2017; 35:827–838.
11.
ShiCW, AschSM, FielderE: Usage patterns of over-the-counter phenazopyridine (Pyridium). J Gen Intern Med, 2003; 18:281–287.
12.
WadeDT, RobsonP, HouseH, et al.: A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil, 2003; 17:21–29.
13.
ChiuB, TaiHC, ChungSD, et al.: Botulinum Toxin A for bladder pain syndrome/interstitial cystitis. Toxins, 2016; 8:201.
14.
WallaceE, TwomeyM, VictoryR, et al.: Intravesical baclofen, bupivacaine, and oxycodone for the relief of bladder spasm. J Pall Care, 2013; 29:49–51.